
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 3.930 | 3.930 | 0.000 |
Shares | 93.850 | 93.850 | 0.000 |
Bonds | 3.290 | 3.290 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 61.598 | 25.481 |
Price to Book | 4.285 | 2.925 |
Price to Sales | 6.052 | 3.863 |
Price to Cash Flow | 20.046 | 17.381 |
Dividend Yield | 0.384 | 1.895 |
5 Years Earnings Growth | 4.239 | 5.647 |
Name | Net % | Category Average |
---|---|---|
Healthcare | 96.670 | 95.707 |
Consumer Defensive | 3.310 | 3.330 |
Industrials | 0.010 | 0.498 |
Technology | 0.010 | 0.705 |
Number of long holdings: 61
Number of short holdings: 1
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Jiangsu Hengrui | CNE0000014W7 | 9.81 | 61.69 | -2.20% | |
Innovent Biologics | KYG4818G1010 | 8.55 | 97.75 | -4.07% | |
Hutchison China | KYG4672N1198 | 8.41 | 241.00 | +2.55% | |
Akeso Inc Ordinary Shares | - | 8.35 | - | - | |
Keymed Biosciences Inc | - | 8.32 | - | - | |
Sichuan Kelun Biotech | CNE1000062J1 | 7.87 | 456.00 | +2.06% | |
BeOne Medicines | CNE100005XT6 | 6.24 | 234.70 | -3.42% | |
RemeGen | CNE100005B03 | 5.96 | 80.80 | +1.66% | |
Hansoh Pharmaceutical Group | KYG549581067 | 3.98 | 38.82 | +4.75% | |
CSPC Innovation | CNE100003K04 | 3.11 | 48.88 | -4.55% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
BOC Income Mixed Securities Inves A | 1.96B | 15.36 | -2.66 | 8.55 | ||
BOC Income Mixed Securities Inves H | 1.96B | 15.34 | -2.65 | - | ||
BOC Thematic Strategy Stock | 1.58B | 16.37 | -2.14 | 7.06 | ||
BOC Sustainable Growth MixSec inv A | 1.33B | 7.10 | -8.66 | 3.35 | ||
BOC Sustain Growth Mixed Sec inv H | 1.33B | 7.03 | -8.70 | - |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review